MED29 Polyclonal Antibody

MED29 is a subunit of the Mediator complex, a multiprotein coactivator of RNA transcription that interacts with DNA-bound transcriptional activators, RNA polymerase II (see MIM 180660), and general initiation factors (Sato et al., 2003

The MED29 Polyclonal Antibody is a highly specific and reliable tool for the detection and analysis of MED29 protein expression in various biological samples. This antibody has been extensively validated for its exceptional performance in immunohistochemistry (IHC), immunofluorescence (IF), and western blotting (WB) applications.

The MED29 protein, also known as Mediator complex subunit 29, plays a crucial role in transcriptional regulation and is involved in the assembly and function of the Mediator complex. Dysregulation of MED29 has been implicated in various diseases, including cancer and neurological disorders. Therefore, the accurate detection and quantification of MED29 protein expression is of utmost importance in both basic research and clinical settings.

The MED29 Polyclonal Antibody has been meticulously developed using high-quality immunogens and state-of-the-art production techniques. It exhibits exceptional specificity towards MED29, ensuring minimal cross-reactivity with other proteins. This antibody demonstrates high sensitivity, enabling the detection of even low levels of MED29 expression.

In IHC applications, the MED29 Polyclonal Antibody produces clear and distinct staining patterns, allowing for precise localization and visualization of MED29 protein in tissue sections. In IF applications, it enables the detection of MED29 in various cellular compartments, facilitating the study of its subcellular localization. Additionally, in WB applications, this antibody reliably detects MED29 protein bands at the expected molecular weight, ensuring accurate quantification.

The MED29 Polyclonal Antibody is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody preparation. It is available in various sizes to accommodate different experimental requirements. Each batch of this antibody undergoes rigorous quality control procedures to ensure consistent and reliable performance.

In summary, the MED29 Polyclonal Antibody is a highly specific and sensitive tool for the detection and analysis of MED29 protein expression. Its exceptional performance in IHC, IF, and WB applications, along with its ease of use and reliable results, make it an invaluable asset for researchers and clinicians alike.